AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
#68 – IDWeek 2022 Recap: Late Breaking Trials and Pipeline Antibacterials
Breakpoints
SCR 109 and C. Diff
SCR 109 was well tolerated through 24 weeks, and the most common side effects were mainly gastrointestinal. Ibiza is a small molecule guanazine analog that competitively inhibits the DNA pool 3C enzyme. It's different from SCR 109 in that it is a C. diff episode treatment product, not prevention for recurrence. The microbiome pearls at the end of these novel C. diff agents are always just so fascinating.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode